A respiratory virus has been spreading in several states that isn’t the flu or a cold. The Centers for Disease Control and Prevention said the number of cases of human metapneumovirus has been growing ...
Sanofi is shelling out $1.15 billion to acquire Vicebio, a startup with a pipeline of respiratory vaccine candidates and a platform technology that will support the pharmaceutical giant’s ambitions to ...
A little-known respiratory virus is making waves across the country. Cases of human metapneumovirus, or HMPV, have been surging in the U.S. since fall 2025. The Center for Disease Control and ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — Sanofi on Tuesday said it would buy the vaccine-focused biotech ...
Among hospitalized children and teens, respiratory syncytial virus (RSV) mostly affects younger, otherwise healthy infants, while the lesser-known human metapneumovirus (HMPV) tends to affect older ...
Cases of a virus with no vaccine and no specific treatment are popping up across the country. It’s called human metapneumovirus, or HMPV, and it's on the rise nationwide, according to data from the ...
TRIAL ON 55 CHARGES TIED TO THE SHOOTING. WELL, IT’S BEEN A ROUGH COLD AND FLU SEASON, AND A LESSER KNOWN VIRUS IS NOW HITTING SCHOOLS AND OFFICES QUITE HARD. IT’S CALLED METAPNEUMOVIRUS OR HMPV, AND ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results